Filter Results:
(2,679)
Show Results For
- All HBS Web
(5,736)
- People (18)
- News (1,951)
- Research (2,679)
- Events (6)
- Multimedia (208)
- Faculty Publications (1,960)
Show Results For
- All HBS Web
(5,736)
- People (18)
- News (1,951)
- Research (2,679)
- Events (6)
- Multimedia (208)
- Faculty Publications (1,960)
Sort by
- 30 Sep 2002
- Research & Ideas
Use the Psychology of Pricing To Keep Customers Returning
same concept can be applied to health care. In its current form, most of us pay for blanket health care coverage that entitles us to a number of periodic services such as... View Details
Keywords: by Manda Mahoney
- 03 Dec 2015
- Op-Ed
How "New Nuclear" Power Could Save the Planet—If Regulators Would Allow It
Leaders from some 150 nations have convened in Paris this week for the COP21 conference with a singular goal: to fight the global threat of climate change. Each of them have brought to Paris their own national plan for reducing greenhouse gas emissions that drive... View Details
- November 2007
- Class Lecture
The Baby Business (FSS)
By: Debora L. Spar
In vitro fertilization and genetic screening are possible with the advent of biotechnology. International adoptions, surrogacy, and other approaches to family planning are on the rise. But few rules govern these measures, medical costs can be prohibitive, and... View Details
Keywords: Governing Rules, Regulations, and Reforms; Policy; Demand and Consumers; Business and Government Relations; Business and Stakeholder Relations; Genetics; Societal Protocols; Commercialization; Health Industry; Health Industry
Spar, Debora L. "The Baby Business (FSS)." Harvard Business School Class Lecture 708-701, November 2007.
- 24 May 2011
- First Look
First Look: May 24
through signature—e.g., at the end of tax returns or insurance policy forms. Yet even when people care about morality and want to be seen as ethical by others, they sometimes transgress when beneficial to... View Details
Keywords: Sean Silverthorne
- 09 Oct 2012
- First Look
First Look: October 9
this time. Read the article: http://hbr.org/2012/10/great-leaders-dont-need-experience/ar/1 Working PapersTeam Scaffolds: How Minimal In-Group Structures Support Fast-Paced Teaming Authors:Melissa Valentine and Amy C. Edmondson Abstract Across many industries,... View Details
Keywords: Sean Silverthorne
- August 2008 (Revised May 2009)
- Background Note
Note on Generic Drugs in the European Union
By: Robert C. Pozen and Elizabeth M. Leonard
Rules governing the introduction of generic drugs in U.S. and EU have some similarities but significant differences because of the Hatch-Waxman Act in the U.S. View Details
Keywords: Governing Rules, Regulations, and Reforms; Government Legislation; Health Care and Treatment; Trademarks; Brands and Branding; Pharmaceutical Industry; European Union; United States
Pozen, Robert C., and Elizabeth M. Leonard. "Note on Generic Drugs in the European Union." Harvard Business School Background Note 309-019, August 2008. (Revised May 2009.)
- August 2001
- Case
Scios, Inc.
Scios, filled with distinguished scientists and experienced managers, nevertheless fails to clear the FDA Phase III process for an important biotechnology drug. This case asks the students to analyze the social costs and benefits of the regulatory process. View Details
- 12 Nov 2001
- Research & Ideas
Facing the New World Order
period. However, the Global Competitiveness Report does include an analysis of the short- or medium-term economic impact of these tragic events and it is cut with a number of specific policy recommendations. I wanted to draw your... View Details
Keywords: by Staff
- October 2021 (Revised January 2022)
- Supplement
Michael Ku and Global Clinical Supply at Pfizer Inc.: Bringing Hope to Patients (C)
By: Linda A. Hill and Emily Tedards
This case is the third installment in a series about the 10-year cultural and digital transformation of Pfizer’s Global Clinical Supply organization. In 2011, Michael Ku became Pfizer’s Vice President of Global Clinical Supply (GCS) after the company had undergone... View Details
Keywords: Clinical Supply Chain; COVID-19; Vaccine; Agile; Innovation and Invention; Change Management; Organizational Culture; Transformation; Leadership; Corporate Strategy; Health Pandemics; Crisis Management; Mission and Purpose; Health Care and Treatment; Supply Chain Management; Digital Transformation
Hill, Linda A., and Emily Tedards. "Michael Ku and Global Clinical Supply at Pfizer Inc.: Bringing Hope to Patients (C)." Harvard Business School Supplement 422-041, October 2021. (Revised January 2022.)
- 14 Feb 2017
- First Look
First Look at New Research: February 14
state court ruled that the Board of Health did not have the authority to implement such a policy, it remains a legally viable option for governments and a voluntary option for restaurants. However, there is very limited empirical data on... View Details
Keywords: Sean Silverthorne
- 05 Aug 2015
- What Do You Think?
What Happened to the ‘Innovation, Disruption, Technology’ Dividend?
W. Norton & Company, 2014). Martin Ford, Rise of the Robots: Technology and the Threat of a Jobless Future (New York: Basic Books, 2015). James L. Heskett, W. Earl Sasser, Jr., and Leonard A. Schlesinger, What Great Service Leaders Know and Do: Creating... View Details
- 01 Oct 2008
- Research & Ideas
How Much Time Should CEOs Devote to Customers?
business and the company's strategy. In a service business like Tesco's, the health of the brand depends heavily on the quality of the millions of daily transactions between shoppers and staff. Motivating the front-line personnel is... View Details
Keywords: by John Quelch
- 2024
- Working Paper
Coronary Artery Bypass Grafting—Impossible to Routine: Case Histories of Transformational Advances
By: Amar Bhidé, Srikant M. Datar and Fabio Villa
We describe how Coronary Artery Bypass Grafting (CABG, or more popularly, “bypass”) operations
revolutionized the treatment of coronary disease (that can produce fatal heart attacks and debilitating
angina). Specifically, we chronicle the: 1) development of the... View Details
Keywords: Health Care and Treatment; Technological Innovation; Innovation Strategy; Technology Adoption; Collaborative Innovation and Invention; Innovation and Invention; Governing Rules, Regulations, and Reforms
Bhidé, Amar, Srikant M. Datar, and Fabio Villa. "Coronary Artery Bypass Grafting—Impossible to Routine: Case Histories of Transformational Advances." Harvard Business School Working Paper, No. 20-010, July 2019. (Revised May 2024.)
- 13 Sep 2011
- First Look
First Look: September 13
business. The book describes a conceptual framework, "the culture cycle," for managing culture that comprises setting and meeting expectations; establishing trust, engagement, and ownership among employees and customers that makes possible the successful... View Details
Keywords: Sean Silverthorne
- 19 Feb 2019
- First Look
New Research and Ideas, February 19, 2019
We conclude with directions for future research. Publisher's link: https://www.hbs.edu/faculty/Pages/item.aspx?num=55591 February 2019 American Economic Journal: Economic Policy Does It Matter If Your Health... View Details
Keywords: Sean Silverthorne
- 07 Mar 2017
- First Look
First Look at New Research, March 7
by maintaining a relatively large balance sheet, even when policy rates have moved well away from the zero lower bound (ZLB). In so doing, it can help ensure that there is an ample supply of government-provided safe short-term... View Details
Keywords: Sean Silverthorne
- 07 Oct 2014
- First Look
First Look: October 7
resources in the ongoing accumulation of scientific knowledge. Publisher's link: http://papers.ssrn.com/sol3/papers.cfm?abstract_id=2478627 October 2014 Research Policy 'Open' Disclosure of Innovations, Incentives and Follow-on Reuse:... View Details
Keywords: Sean Silverthorne
- December 2007 (Revised July 2009)
- Case
Given Imaging Ltd. - First We Take Manhattan, Then We Take Berlin?
GI has developed a revolutionary video pill for imaging the small bowel in the gastro-intestinal tract. The development has required the integration of wide variety of technologies. GI founder and CEO Gabriel Meron must determine GI's marketing strategy and prioritize... View Details
Keywords: Medical Specialties; Globalized Markets and Industries; Decisions; Technological Innovation; Marketing Strategy; Market Entry and Exit; Entrepreneurship; Health Care and Treatment; Corporate Finance; Medical Devices and Supplies Industry; Japan; United States; Europe
Isenberg, Daniel J. "Given Imaging Ltd. - First We Take Manhattan, Then We Take Berlin?" Harvard Business School Case 808-033, December 2007. (Revised July 2009.)
- 14 May 2019
- Research & Ideas
Ethics Bots and Other Ways to Move Your Code of Business Conduct Beyond Puffery
When health insurer Cigna Corp. appeared in front of a judge for allegedly misleading shareholders on Medicare regulations this spring, plaintiffs thought they had a strong case. After all, Cigna had published its own document titled... View Details
Keywords: by Michael Blanding
- 24 Sep 2013
- First Look
First Look: September 24
Earnings Call By: Eccles, Robert G., and George Serafeim Abstract—One of the challenges companies claim to face in making sustainability a core part of their strategy and operations is that the market does not care about sustainability,... View Details
Keywords: Sean Silverthorne